Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Service As a Strategy, Not a Buzzword

Jim Durham

Every touch point a client has with a firm can contribute meaningfully to client satisfaction ' or dissatisfaction.

Features

Managing Religious Diversity in the Workplace

Rebekah Mintzer

In the U.S. workplace, increasing religious diversity means additional labor and employment responsibilities for in-house counsel, according to a new report from the Tanenbaum Center for Religious Understanding.

Features

Whistleblower Retaliation Cases

Janie F. Schulman

Recent notable whistleblower cases are in some instances defining what it takes to be a successful retaliation plaintiff; in other ways, these cases are merely shaping the battleground for cases yet to come.

The Importance of Background Checks

Thomas E. Zeno

The government routinely requires certifications from its contractors, who provide everything from weapons systems used in combat to health care services paid by Medicare and Medicaid.

Features

Non-Compete Agreements

Chad W. Moeller & William J. Tarnow II

Rulings in two cases have substantially defined the landscape of non-competition law in Illinois, and have a profound impact on employers' use of restrictive covenants with their employees.

Features

Anti-Assignment Clause?

Steven B. Smith & Dana Gale Hefter

The Third Circuit recently reaffirmed the policy underlying anti-assignment provisions in connection with bankruptcy cases, and the extent of bankruptcy courts' jurisdiction after closure of a case.

Features

<i>In re Bellingham Ins. Agency</i>

By Yitzhak Greenberg

The Supreme Court <I>may</I> finally clarify some of the confusion regarding a bankruptcy court's authority acknowledged by Justice Scalia in <I>Stern</I>.

Seventh Circuit Stumble

Dion W. Hayes & Aaron G. Mccollough

As fallout from <I> Stern v. Marshall</I> continues to disrupt bankruptcy litigation throughout the country, the Seventh Circuit recently provided a new contribution to the body of post-<I>Stern</I> authority from the Court of Appeals level.

Columns & Departments

Decisions of Interest

ALM Staff & Law Journal Newsletters

Analysis of recent important rulings.

NJ & CT News

ALM Staff & Law Journal Newsletters

A look at what's happening of importance in neighboring states.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES

  • Surveys in Patent Infringement Litigation: The Next Frontier
    Most experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.
    Read More ›
  • In the Spotlight
    On May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug &amp; Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.
    Read More ›